We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Poison pen

3 Dec 2021 By John Foley

A slowdown in demand ripped $18 bln off the digital document-signing firm’s market value. The company’s response – spending more to revive sales – adds to the near-term pain. For profitless companies reliant on ambitious forecasts, sharp corrections are a signature move.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)